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Abstract
Genetic association studies have become an important part of our scientific landscape. This
commentary discusses some basic scientific issues which should be considered when reporting and
evaluating such studies including SNP Discovery, Genotyping and Haplotype Analysis; Population
Size, Matching of Cases and Controls, and Population Stratification; Phenotype Definition and
Multiple Related Phenotypes; Multiple Testing; Replication; Genome-wide Association Studies
(GWAS); and the Role of Functional Studies. All of these elements are important in evaluating such
studies and should be carefully considered when these studies are conceived and carried out.
Introduction
Genetic association studies have become an important
part of our scientific landscape. They add a unique per-
spective to our understanding of the pathogenesis of dis-
ease, and often present unique candidates for mechanistic
studies. The number of such studies has been increasing
exponentially: a recent Pub Med search for "Genetic Asso-
ciation Studies" limited to "humans" and English"
resulted in more than 24,000 citations. The form that
these studies are taking is being driven not only by scien-
tific issues (scientific questions, availability of well charac-
terized populations), but also by rapid advances in
technology. Whereas it was once reasonable to report one
or a few single nucleotide polymorphisms (SNPs) in an
association study, advances in our ability to perform high
through-put DNA sequencing and genotyping mandate
that current publications report a more comprehensive
analysis of genetic variations in a target, than would have
been required in the recent past. In fact, chips are now
available which can identify more than 370,000 to as
many as 1 million SNPs, which span the entire human
genome. In part because of these capabilities, the NHLBI
has recently funded 13 centers (STAMPEED) to perform
genome-wide association studies in heart, lung, blood,
and sleep disorders; 3 of these centers focus on asthma
and lung diseases.
In view of such advances, what new metrics do the scien-
tific community and this Journal require for articles sub-
mitted for publication? These issues are also of interest to
other journals, as shown by the publication of perspec-
tives which discuss these issues [1-3]. Accordingly, several
aspects of study design are paramount when submitting a
manuscript for publication. These include: 1) Adequacy of
SNP discovery, completeness of the genotyping, and ade-
quacy of haplotype analysis; 2) Study population size, the
matching of cases and controls, and whether the issue
population stratification has been addressed; 3) Defini-
tion of phenotype for primary and secondary analyses,
and the examination of multiple, interrelated phenotypes;
4) How the issue of multiple testing and multiple compar-
isons has been addressed; 5) Replication of positive find-
ings in additional study populations, if they are available,
and the extent to which biologic plausibility can substi-
tute for replication, particularly if replicate populations
are unavailable; 6) Approach to genome-wide association
studies; and 7) Role of functional studies in association
studies. Table 1 lists these elements and our comments
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concerning them. A number of recent articles have
addressed some or all of these issues [4-9]. Other reviews,
which also include the topic of genome-wide association
studies (GWAS), are also informative [10-12].
SNP Discovery, Genotyping and Haplotype 
Analysis
While there are now many on-line resources which
describe the variability (SNPs) in genes of interest in dif-
ferent populations (e.g. HapMap Project), these tools may
be incomplete, not representative of the population stud-
ied, may not include important functional polymor-
phisms, and may be inaccurate. With recent advances in
sequencing technologies, re-sequencing of target genes is
much less onerous than in the past. For this reason, re-
sequencing of the target gene(s) in either the target popu-
lation, or a comparable one, should be considered to con-
firm/identify all important variations in the gene, and to
devise an efficient genotyping strategy for the population
under investigation. The number of individuals which
should be sequenced depends on the whether only com-
mon SNPs are of interest, or whether rare variations in the
gene are also of interest [13]. Currently, there is little jus-
tification to report incomplete genotyping for any genetic
target in an association study.
Genotyping methods have evolved greatly over the past
decade. Older approaches such as single-stranded confor-
mational polymorphism (SSCP), denaturing high per-
formance liquid chromatography (dHPLC), and
amplified-refractory mutation system (ARMS), have
largely given way to newer and more reliable techniques
such as TaqMan, Sequenom (mass spectrometry), and
rapid throughput sequencing. Some variants, such as
SNPs in repetitive elements, can prove problematic for
genotyping. Therefore investigators should confirm the
accuracy of at least a subset of genotypes using a second
technique to ensure accuracy. Results must be evaluated
for Hardy-Weinberg equilibrium. Haplotype analyses
should be routinely performed and reported. As we have
become more efficient in these technologies reporting
analyses of pathways containing multiple genes, rather
than a single gene should be expected. There is little justi-
fication for reporting a single or few SNPs in a single gene.
Population Size, Matching of Cases and 
Controls, and Population Stratification
Recent publications have stressed the importance of ade-
quate population size, the matching of cases and controls,
and the related issue of population stratification
[1,3,5,9,14]. As recently stated by Hunter [3] citing
Wacholder [15], "a "statistically significant" finding in an
underpowered study is more likely to be a false positive
result due to chance than is such a finding in an ade-
quately powered study, and "statistically significant" asso-
ciations could be attributed to systemic bias (e.g. from
confounding due to ethnic ancestry, also known as popu-
lation stratification.)" Hall [1] has recently published a
table with a suggested number of cases according to geno-
type relative risk, minor allele frequency, and dominant/
recessive effect. For example, for a genotype relative risk of
1.5, a dominant effect, and a minor allele frequency of
Table 1: Criteria for Evaluating Genetic Association Studies
Elements Comment
SNP Discovery and Genotyping (Completeness) SNP discovery and genotyping of a gene should be complete (based on current literature 
AND re-sequencing of the gene in a subgroup of the population studied).
Haplotype Analysis Haplotype analyses should be reported.
Population Size Size should be large enough to have reasonable power to avoid both false negative and 
false positive results
Matching Cases and Controls Appropriate matching is always a consideration
Population Stratification Population stratification should always be addressed (in some manner)
Phenotype Definition The best genetic association studies employ a robust definition of the phenotype (i.e. a 
physician's diagnosis of asthma is much less robust than one based on physiologic and 
clinical criteria)
Multiple Testing (Comparisons)
Inter-Related Phenotypes
Issue of multiple testing must always be addressed, while acknowledging that some 
phenotypes are inter-related (and not independent), and Bonferroni correction may be 
too conservative
Replication and Role of Functional Studies Replication is necessary unless it cannot be reasonably performed. In some cases, 
functional studies substitute for replicationRespiratory Research 2009, 10:109 http://respiratory-research.com/content/10/1/109
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0.05, 1,300 cases would be required for an α of 0.05 and
power of 90%. However, only several hundred cases (300
to 750) would be required for a larger genotype relative
risk and/or a larger minor allele frequency. A recessive
effect would require more cases than a dominant one. In
addition, cases and controls need to be matched for
important variables, including ethnic background. While
this can often be done on the basis of shared geography,
this approach is not always sufficient. The genotyping of
ancestry informative markers (AIMs) to address popula-
tion stratification is important, particularly as the cost of
genotyping continues to fall. Another approach may use
family-based association studies [e.g.  [16]]. The large
number of SNPs identified in GWAS studies provides
another mechanism for performing this analysis.
Phenotype Definition and Multiple Related 
Phenotypes
One of the most important considerations in genetic asso-
ciation studies concerns phenotype description, namely,
1) the phenotype definition; and 2) use of multiple, often
inter-related phenotypes.
A phenotype under investigation can often be character-
ized using various definitions, which can differ in accu-
racy. For example, an "asthma" phenotype can be
assumed based on patient provided answers to a ques-
tionnaire; because a patient has received a physician's
diagnosis of "asthma;" or because a physician's diagnosis
has been confirmed by physiological testing (i.e. bron-
chodilator reversibility and/or airway hyperresponsive-
ness to methacholine). The last definition is more
stringent than the first two, and different phenotype defi-
nitions might lead to the inability to replicate a genetic
association.
Some phenotypes can be defined using multiple defini-
tions. For example, bronchodilator reversibility can be
defined as the absolute change in FEV1 after bronchodila-
tor administration, the percent change in FEV1 from base-
line, or the change based on the FEV1 percent predicted. If
an association for bronchodilator reversibility is "repli-
cated" in two populations using different definitions for
bronchodilator reversibility, should some statistical
adjustment be made for these multiple comparisons/mul-
tiple definitions?
Finally, many genetic association studies explore several
related phenotypes. For example, genetic associations
studies in asthma often include the phenotypes "asthma"
(defined by one or more ways described above; bronchial
hyperresponsiveness; serum IgE level; lung function
(often in several different ways such as FEV1, FEV1/FVC
ratio, etc.); and bronchodilator reversibility. Rationales
for how statistical adjustments are performed when exam-
ining multiple, highly correlated endpoint should be
clearly stated.
Finally, while many genetic association studies are truly
exploratory, the most robust studies test a single or lim-
ited number of specific hypotheses, based on biologic
plausibility and/or previous findings. These considera-
tions help formulate the basis of a sound statistical analy-
sis plan that can be convincingly described for both
reviewers and readers.
Multiple Testing
All genetic association studies must address the issue of
multiple testing and comparisons [1,3,9]. While it is
widely considered that the Bonferroni correction is too
conservative a correction for most purposes, the standard
p value of 0.05 is similarly too liberal. Approaches to this
problem include a formal permutation analysis [17]) or
(somewhat arbitrarily) choosing a more stringent p value
for significance (e.g. 0.01 or 0.001). One can also choose
the highest ranked SNPs in an exploratory population
(from a threshold p value or other factor), to identify a lim-
ited number of SNPs to be examined in a replication popu-
lation. Whether independent or interdependent
phenotypic endpoints are examined raise another impor-
tant consideration for multiple testing. That is, a finding
might not be considered to be "replicated" if marginal p
values (e.g. p = 0.04) were observed in two populations
for the same SNP, but with different definitions of the
same phenotype (e.g. bronchodilator reversibility defined as
the absolute increase in FEV1 in one population and as the
% increase over baseline in a second population, or lung
function defined as FEV1 in one population and FEV1/FVC
ratio in a second population).
Replication
Any positive finding in a genetic association study needs
to be replicated in one or more additional populations,
assuming such population(s) exist [1,3,5,9,18]. This is
particularly important in genome-wide association stud-
ies [2,3,6,10,12]. Exactly what constitutes replication,
however, needs to be considered from the point of view of
both of the SNP(s) involved and the phenotype(s) repli-
cated.
In the simplest case, an association is replicated if the
same SNP or haplotype is associated with the phenotype,
in the same direction, in two or more populations. (In the
recent past, some might have considered [and may still
consider] an association replicated, even if the direction of
the phenotypic association were in opposite directions in
two populations.) A finding can also be considered to be
replicated if SNP1 is associated with a phenotype in pop-
ulation 1 and SNP2 is associated with the same phenotype
in population 2, if SNP1 and SNP2 are in perfect linkage dis-Respiratory Research 2009, 10:109 http://respiratory-research.com/content/10/1/109
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equilibrium (D' or R2 of 1.0). Two measures of linkage dis-
equilibrium are in common usage, D' and r2. D' measures
unidirectional linkage disequilibrium (e.g. knowing the
value of SNP1, you are certain of the value of SNP2; how-
ever, knowing the value of SNP2, you may not know the
value of SNP1). r2 is a measure of bidirectional linkage
disequilibrium (e.g.  it is the traditional correlation of
SNP1 and SNP2). Whether a D' or r2 value less than 1.0
(such as 0.8) is sufficient to use SNP2 as a surrogate for
SNP1 in a replication study is open to debate. Finally, in
attempting to replicate a specific finding (SNP1) in a sec-
ond population, investigators may fail to replicate the spe-
cific SNP (SNP1), but then discover stronger associations
in additional closely related SNPs; this could occur if
SNP1 were not in strong linkage disequilibrium with the
causal SNP, while the newly associated SNPs were [9].
Approaches using systemic meta-analytic techniques have
been suggested as another approach for replicating genetic
association studies [18].
Should a finding be considered replicated if the same
SNP/haplotype were found to be associated in two popu-
lations, not with exactly the same phenotype, but in a
related one (e.g. different definitions of the same pheno-
type [asthma defined by doctor's diagnosis versus physio-
logic criteria) or through the use of two related
phenotypes (e.g. lung function defined by FEV1 and FEV1/
FVC ratio)? Such circumstances require interpretation by
the investigators, reviewers and editors. Among the factors
which should be considered when considering this issue
are 1) how close either the different phenotype definitions
or related phenotypes track with one another, and 2) the
strength of the associations. Strong statistical associations
(P < 0.001) with related phenotypes, are more convincing
than weak associations (p = 0.04).
Genome-wide Association Studies (GWAS)
Genome-wide association studies have both their own
advantages, and concerns, recently discussed in a number
of commentaries and articles [2,3,6,10,12]. All of the
issues discussed above are also pertinent for genome-wide
association studies, with an emphasis on the issue of rep-
lication. In this case, multiple populations are required,
often using a technique of nested replication. A recent
report provides useful information concerning power cal-
culations for genome-wide association studies [19]. In
addition, the effects of copy number variations (CNVs)
should also be considered. Finally, "a central challenge in
this area is the development of powerful multipoint meth-
ods that can detect variants that have not been directly
genotyped" [20]. Accordingly, techniques have recently
been reported for addressing the issue of missing data in
genome-wide analyses using the techniques of imputa-
tion [20] and Markov chain haplotyping [21].
Role of Functional Studies
Functional studies which can help clarify mechanism can
counterbalance deficiencies in some genetic association
studies. Such data, however, should not be required in all
genetic association studies since SNPs found to be impor-
tant in genetic association studies may produce no change
in protein expressed (synonymous), may be located in
non-coding regions (introns or 5' or 3' untranslated
regions), and/or may require an intact organism/animal/
human in order to demonstrate physiological relevance.
Conclusion
This commentary discusses many of the issues that must
be addressed in performing and reporting genetic associa-
tion studies, including SNP discovery, genotyping and
haplotype analysis; population size, matching of cases
and controls, and population stratification; phenotype
definition and the issue of multiple related phenotypes;
multiple testing; replication; and the special issues of
genomewide association studies and functional studies.
All of these issues must be addressed to ensure high qual-
ity genetic association studies. The extent, to which
authors can address these issues, plus the novelty and
importance of their observations, will play a major role in
determining the suitability of the manuscript for publica-
tion.
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